Lexaria Bioscience Corp. began developing its DehydraTECH™ technology in 2014 and has since strengthened and broadened the technology to an unprecedented degree. Lexaria is a global leader in enhancing the speed and efficiency of orally-delivered fat-soluble active molecules and drugs.
Lexaria has also demonstrated early-stage effectiveness in improving delivery through human skin for the potential development of topically...
Lexaria Bioscience Corp. began developing its DehydraTECH™ technology in 2014 and has since strengthened and broadened the technology to an unprecedented degree. Lexaria is a global leader in enhancing the speed and efficiency of orally-delivered fat-soluble active molecules and drugs.
Lexaria has also demonstrated early-stage effectiveness in improving delivery through human skin for the potential development of topically-administered products, including patches, creams and lotions.
Lexaria’s technology is currently being evaluated for improved delivery characteristics of antiviral drugs in the global fight against COVID-19.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.